T-cell Lymphoma
Conditions
Keywords
non cutaneous peripheral t-cell lymphoma with nodal involvement
Brief summary
Evaluation of CD4 in combination with CHO chemotherapy in subjects with nodal involvement of non cutaneous Tcell lymphoma.
Interventions
BIOLOGICALCHOP + CD4
DRUGCHOP
Sponsors
Emergent BioSolutions
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* study is closed to enrollment
Exclusion criteria
* study is closed to enrollment
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Primary Outcome Unavailable | — | All efforts to obtain data have been exhausted, therefore we have no data available to report. |
Participant flow
Pre-assignment details
All efforts to obtain data have been exhausted, therefore we have no data available to report.
Participants by arm
| Arm | Count |
|---|---|
| 1 CHOP Chemo Therapy + CD4 Therapy CHOP + CD4 CHOP chemo therapy + CD4 therapy
CHOP + CD4 | 0 |
| 2 CHOP Chemotherapy CHOP CHOP chemotherapy
CHOP | 0 |
| Total | 0 |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | — / — | — / — |
| other Total, other adverse events | 0 / 0 | 0 / 0 |
| serious Total, serious adverse events | 0 / 0 | 0 / 0 |
Outcome results
Primary
Primary Outcome Unavailable
All efforts to obtain data have been exhausted, therefore we have no data available to report.
Population: All efforts to obtain data have been exhausted, therefore we have no data available to report.